Loading ...

Error:
Message:
Pharma Partnering since 1995. Made in Europe for the World.

Delegates' Comments

„In euroPLX we find a good set of business opportunities…“
Miquel Mas de les Valls and Vikas Dahiya
"…results that would never have been achieved otherwise."
Larry Hay
"…euroPLX is a superb premium event…"
Anıl Okay and Cengiz Zaim
"…we have used and trusted the euroPLX platform…"
Denis Asmar-Kristiansen and Gediminas Katunskis
"…the most effective way to explore new opportunities…"
Silvia Ferlin and Diego Ingrassia
"…an opportunity to share and learn…"
Jordi Sarra
"…our most important business development tool…"
Mohammed Alkraida and Dr. Islam Alayary
"…most effective tool for business development…"
Ray Yang
"We have concluded a number of deals…"
George Th. Liolios and Xanthippos Xanthakis
"…euroPLX meetings have been a vital part of our product sourcing strategy…"
Petter Homdrum
"…the best value for money event for the licensing community…"
Andreas Loizou
"…the most important tool for our business development…"
Dr. Islam Alayary and Dr. Mohamed Alfadli
"…excellent format for finding new business opportunities…"
Joan and Steve Short
"…two pleasant days in a very supportive atmosphere…"
Liana Naim
"…the most effective Business Development tool I use…"
Nickolay Javoronkov
"…an enjoyable occasion to meet up with new companies."
Dr. Richard Sewalt and Siedo Bron
"…euroPLX is an ideal platform to extend our base…"
Ruud Koolen and Esther Kranenburg
"…euroPLX is an important business development tool."
Michael Winstrøm
"…euroPLX is a rare and reputable place where the right people meet."
Valery Tupolev
"…I've never left a euroPLX without new business challenges…"
Akis Chondrogiannis
"…have achieved a number of successful deal outcomes…"
Paul Phull
"…four times as much for half the price…"
Anke Rau and Dr. Norbert Rau
"euroPLX is sometimes tough and intense…"
Sebastien Sanial and Malgorzata Derewianka
"We were Platinum Sponsors of euroPLX 49 Istanbul, because…"
Rich DiCicco
"We became a returning attendee as we've never left empty-handed…"
Kees Trommelen
"…get focused on the business...just business!"
Dragan Lutz and Mario Vlasic
"I have successfully used the euroPLX meetings for licensing-in and licensing-out…"
Dr. Satyendra Kumar
"…meet your business partners at the well organized events…"
Peter van Hoogstraten and Paul C. Borghouts
"…a highly effective and pleasant way to meet…"
Ronald Kriek and Wouter Hanegraaf
"…interact with so many companies…"
Simona Aganovic and Guy Clark
"We get value for our money…"
Vilas Nagare and Sundeep V. Bambolkar
"It’s the best partnering event…"
Jinang Parekh and Vijay Agarwal
"…the only partnering conference that covers all aspects of business development…"
Dr. Hubert Ridolphi and Dr. Gerrit Hagens
"...good place to expand your international network..."
Ramon Brusco
"…one of the few events which attracts a cross section of attendees from all pharmaceutical sectors…"
Daniel Jones
"…the best time and cost effective way to meet new partners."
Nuray Acar and Mutlu Topal
"There is no end to new challenges at euroPLX"
Ruud Koolen
"…a basis for excellent business."
Ana Paula Branco and José Roberto Pereira
"euroPLX is the most cost-effective and time-saving way…"
David Zubeldía
"…good opportunity for meeting with many relevant players…"
Dietmar Jannaschk and Gemma Mogas
"…euroPLX is the perfect place…"
Gustavo Samojeden and Hernán Bouzada
"…efficient and fruitful one-to-one discussions…"
Sylvie Fondanayche
"We are not aware of any other event where you can meet so many interesting partners…"
Holger and Kai Schleenhain
"I rate euroPLX very high…"
Reynhardt Van As
"euroPLX is the best pharma meeting…"
Santiago, Mar, and Josémaria Calzada
"…very good opportunity to meet existing and new business partners…"
Agnes Olszanowski and Dr. Marian Takac
"I never leave euroPLX empty-handed."
Wendell Clayton
"…the best possible way to contact a large number of people…" Shala Fardaei and Ineke Braat
"It was in this forum that we forged some of our major alliances…" Nimit Jhaveri and Biplab Kar
"…we have made a lot of money on euroPLX deals…"
Rich DiCicco
"…an ideal opportunity to meet…"
Andreas Wagner & Michel Blanc
"…extremely time and cost efficient way to make new business contacts…"
Wolfgang Bäurle
"euroPLX is the most efficient event I know…"
Patsy Carney
"…the most efficient of the Business Development forums…"
Roland Brown
"…a tremendous opportunity to network intensely…"
Elzbieta Weston & Jacek Plucienniczak

Sponsors for Recent Meeting


Media Sponsors

Pharmalicensing
currentPartnering
GenericsWeb
Generics Bulletin
OTC Bulletin
transkript
EUBIO
PharmaPhorum
Source OTC
OTC Toolbox
Lingmed Logo


euroPLX 41 Barcelona

35 Countries Represented at Barcelona's Leading Pharma Partnering Event!

Click to view registered companies

euroPLX 41 Barcelona
was held on November 2 + 3, 2009, in Barcelona, Spain

More than 150 pharma and biotech industry delegates from 35 countries convened at euroPLX 41 Barcelona in order to discuss and negotiate pharma deals. Barcelona's leading pharma partnering event featured an average of 23 pre-scheduled one-on-one negotiations per participating company on two conference days. Participants praised the high level of business offers and negotiations.

Almost 30% of the participating companies were new-comers, i.e. they have never had a delegate at a euroPLX Meeting before. Most of the new-comers were attracted to euroPLX by word of mouth.

euroPLX 41 Barcelona Flyer
e41Meeting

Registered Companies

The country names designate the places where the attending delegates are based, not necessarily the respective company's headquarters!

Elpen Pharma GmbH (Germany)
Laboratorios Llorens S.L. (Spain)
SCM Health srl (Italy)


Contact us

phone: +49 (6221) 426296-0
e-mail: please go to contact form

euroPLX Business Developer

Receive the euroPLX newsletter!
read more

Dynamic Partnering Focus


Hourly updated partnering interests areas of registrants
General Interest Areas
Products for (click to view)
Hospital
percent
55%
Practitioner
percent
71%
Consumer
percent
67%

Development Stage (click to view)
Preclinical
percent
14%
Phase I/II
percent
14%
Phase III
percent
37%
Approved
percent
78%

IP status (click to view)
Patented
percent
71%
Biosimilar
percent
0%
Generic
percent
63%

Product category (click to view)
Prescription
percent
86%
Over-the-Counter
percent
65%
Food supplements
percent
35%

Supporting items (click to view)
Drug delivery technology
percent
33%
Medical devices
percent
33%
Diagnostics
percent
8%

Services (click to view)
R&D services
percent
14%
Clinical research services
percent
0%
Regulatory services
percent
14%
Contract manufacture
percent
25%
API supply
percent
14%
Finished product supply
percent
67%

Therapeutic Interest Areas
Cardiovascular
percent
45%
Immunology
percent
33%
Oncology
percent
47%
CNS, Neurology
percent
55%
Gastroenterology
percent
51%
Urology
percent
33%
Female/Male health
percent
47%
Pain
percent
53%
Respiratory
percent
47%
Dermatology
percent
59%
Musculo-skeletal
percent
39%
Metabolism/Endocrinology
percent
41%
Ophthalmology
percent
33%
Other therapeutic areas
percent
47%


Copyright by RauCon 1996-2014